Gritstone Oncology, Inc.

( )
GRTS PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
Health Technology » Pharmaceuticals Major
JNJJohnson & Johnson -2.05%153.020.7%$1306.12m
PFEPfizer Inc. -0.41%34.250.9%$1242.18m
BMYBristol-Myers Squibb Co. -2.34%59.331.0%$835.72m
MRKMerck & Co., Inc. -1.56%72.160.7%$813.86m
ABBVAbbVie, Inc. -1.04%105.601.9%$781.39m
LLYEli Lilly & Co. -0.61%200.761.1%$735.02m
AZNAstraZeneca Plc 0.15%47.231.2%$488.03m
GSKGlaxoSmithKline Plc 0.12%34.280.2%$274.31m
NVSNovartis AG -0.83%83.480.2%$171.68m
SNYSanofi 0.97%45.900.2%$170.62m
VTRSViatris, Inc. -2.09%13.590.0%$131.11m
VERUVeru, Inc. -7.30%12.190.0%$100.47m
CVACCureVac NV -2.67%81.330.0%$92.55m
NVONovo Nordisk A/S -3.15%69.210.1%$88.01m
KALVKalVista Pharmaceuticals, Inc. -1.96%31.560.4%$81.61m

Company Profile

Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.